Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines
New Journal of Chemistry · 2024 · 48 (18) · 8038-8054
DOI: 10.1039/d4nj00824c ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Chemistry, 2024. Verfasst von K. Fabitha und 9 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Engineering Research Board, Ministry of Education, India, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Nitrogen-based heterocycles substituted fused pyran derivatives (6a–e, 8a–e, 10a–e, 12a–e, & 14a–e) have been synthesized and tested for their in vitro anticancer efficacies against MCF7, A549, and HCT116 cancer cell lines.
Förderung
- Science and Engineering Research Board
- Ministry of Education, India
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Fabitha, K., Kallingal, A., Maciejewska, N., Arya, C. G., Chandrakanth, M., Thomas, N. M., Li, Y., Gondru, R., Munikumar, M., & Banothu, J. (2024). Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines. New Journal of Chemistry, 48(18), 8038-8054. https://doi.org/10.1039/d4nj00824c
Vancouver
Fabitha K, Kallingal A, Maciejewska N, Arya CG, Chandrakanth M, Thomas NM, et al. Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines. New Journal of Chemistry. 2024;48(18):8038-8054. doi:10.1039/d4nj00824c
BibTeX
@article{Fabitha2024,
author = {Fabitha, K. and Kallingal, Anoop and Maciejewska, Natalia and Arya, C. G. and Chandrakanth, Munugala and Thomas, Neethu Mariam and Li, Yupeng and Gondru, Ramesh and Munikumar, Manne and Banothu, Janardhan},
title = {Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines},
journal = {New Journal of Chemistry},
year = {2024},
volume = {48},
number = {18},
pages = {8038--8054},
doi = {10.1039/d4nj00824c}
}
EUVIMED